{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:12:17Z","timestamp":1789506737348,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["MOP-74430"],"award-info":[{"award-number":["MOP-74430"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["MOP-119408"],"award-info":[{"award-number":["MOP-119408"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["PJT-361493"],"award-info":[{"award-number":["PJT-361493"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"crossref","award":["MOP-114988"],"award-info":[{"award-number":["MOP-114988"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"crossref","award":["950-200810"],"award-info":[{"award-number":["950-200810"]}],"id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Canada Foundation for Innovation Leadership Opportunity Fund","award":["27592"],"award-info":[{"award-number":["27592"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jad.2017.02.023","type":"journal-article","created":{"date-parts":[[2017,2,17]],"date-time":"2017-02-17T02:20:26Z","timestamp":1487298026000},"page":"172-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["The interaction of GSK3B and FXR1 genotypes may influence the mania and depression dimensions in mood disorders"],"prefix":"10.1016","volume":"213","author":[{"given":"Alexandre","family":"Bureau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Martin","family":"Beaulieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Paccalet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvon C.","family":"Chagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Maziade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2017.02.023_bib1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/archpsyc.1992.01820080023004","article-title":"The comprehensive assessment of symptoms and history (CASH). An instrument for assessing diagnosis and psychopathology","volume":"49","author":"Andreasen","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.023_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1503\/jpn.110011","article-title":"A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health","volume":"37","author":"Beaulieu","year":"2012","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.jad.2017.02.023_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1146\/annurev.pharmtox.011008.145634","article-title":"Akt\/GSK3 signaling in the action of psychotropic drugs","volume":"49","author":"Beaulieu","year":"2009","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.jad.2017.02.023_bib4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cell.2007.11.041","article-title":"A beta-arrestin 2 signaling complex mediates lithium action on behavior","volume":"132","author":"Beaulieu","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.jad.2017.02.023_bib5","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1073\/pnas.0711496105","article-title":"Role of GSK3beta in behavioral abnormalities induced by serotonin deficiency","volume":"105","author":"Beaulieu","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jad.2017.02.023_bib6","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1176\/appi.ajp.2012.12070908","article-title":"Association of GSK-3beta genetic variation with GSK-3beta expression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia","volume":"170","author":"Blasi","year":"2013","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.023_bib7","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.biopsych.2013.03.004","article-title":"Follow-up of a major psychosis linkage site in 13q13-q14 reveals significant association in both case-control and family samples","volume":"74","author":"Bureau","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.023_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nature10524","article-title":"Temporal dynamics and genetic control of transcription in the human prefrontal cortex","volume":"478","author":"Colantuoni","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jad.2017.02.023_bib9","doi-asserted-by":"crossref","first-page":"E4610","DOI":"10.1073\/pnas.1506491112","article-title":"FXR1P is a GSK3beta substrate regulating mood and emotion processing","volume":"112","author":"Del'Guidice","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jad.2017.02.023_bib10","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jamapsychiatry.2015.3018","article-title":"Analyzing the role of microRNAs in schizophrenia in the context of common genetic risk variants","volume":"73","author":"Hauberg","year":"2016","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2017.02.023_bib11","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddw181","article-title":"Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder","author":"Hou","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.jad.2017.02.023_bib12","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fnmol.2011.00016","article-title":"Glycogen synthase kinase-3 in the etiology and treatment of mood disorders","volume":"4","author":"Jope","year":"2011","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.jad.2017.02.023_bib13","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.93.16.8455","article-title":"A molecular mechanism for the effect of lithium on development","volume":"93","author":"Klein","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.jad.2017.02.023_bib14","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1038\/ejhg.2012.67","article-title":"Symptom dimensions as alternative phenotypes to address genetic heterogeneity in schizophrenia and bipolar disorder","volume":"20","author":"Labbe","year":"2012","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.jad.2017.02.023_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.schres.2012.12.022","article-title":"A protective-compensatory model may reconcile the genetic and the developmental findings in schizophrenia","volume":"144","author":"Maziade","year":"2013","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2017.02.023_bib16","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1176\/ajp.149.12.1674","article-title":"Reliability of best-estimate diagnosis in genetic linkage studies of major psychoses: results from the Quebec pedigree studies","volume":"149","author":"Maziade","year":"1992","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.023_bib17","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1176\/ajp.152.10.1458","article-title":"Negative, psychoticism, and disorganized dimensions in patients with familial schizophrenia or bipolar disorder: continuity and discontinuity between the major psychoses","volume":"152","author":"Maziade","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.023_bib18","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/sj.mp.4001594","article-title":"Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a dense genome scan in Eastern Quebec families","volume":"10","author":"Maziade","year":"2005","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.023_bib19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1086\/301904","article-title":"PedCheck: a program for identification of genotype incompatibilities in linkage analysis","volume":"63","author":"O'Connell","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.jad.2017.02.023_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.schres.2016.04.038","article-title":"Liability indicators aggregate many years before transition to illness in offspring descending from kindreds affected by schizophrenia or bipolar disorder","author":"Paccalet","year":"2016","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.jad.2017.02.023_bib21","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/bdi.12346","article-title":"Early-onset and very-early-onset bipolar disorder: distinct or similar clinical conditions?","volume":"17","author":"Propper","year":"2015","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.02.023_bib22","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1176\/ajp.154.12.1726","article-title":"Clinical and methodological factors related to reliability of the best-estimate diagnostic procedure","volume":"154","author":"Roy","year":"1997","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2017.02.023_bib23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","author":"Schizophrenia Working Group of the Psychiatric Genomics\u00a0Consortium","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jad.2017.02.023_bib24","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.15252\/emmm.201505696","article-title":"Accumulated common variants in the broader fragile X gene family modulate autistic phenotypes","volume":"7","author":"Stepniak","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.jad.2017.02.023_bib25","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1399-5618.2007.00388.x","article-title":"Early age at onset of bipolar disorder is associated with more severe clinical features but delayed treatment seeking","volume":"9","author":"Suominen","year":"2007","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2017.02.023_bib26","doi-asserted-by":"crossref","unstructured":"Woodgett, J.R., 2001. Judging a protein by more than its name: GSK-3. Science\u2019s STKE: Signal Transduction Knowledge Environment 2001. RE12.","DOI":"10.1126\/stke.2001.100.re12"},{"key":"10.1016\/j.jad.2017.02.023_bib27","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.2307\/2531734","article-title":"Models for longitudinal data: a generalized estimating equation approach","volume":"44","author":"Zeger","year":"1988","journal-title":"Biometrics"},{"key":"10.1016\/j.jad.2017.02.023_bib28","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1093\/schbul\/sbv116","article-title":"Association of a schizophrenia risk variant at the DRD2 locus with antipsychotic treatment response in first-episode psychosis","volume":"41","author":"Zhang","year":"2015","journal-title":"Schizophr. Bull."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717301040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032717301040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T13:48:18Z","timestamp":1584020898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032717301040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":28,"alternative-id":["S0165032717301040"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2017.02.023","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The interaction of GSK3B and FXR1 genotypes may influence the mania and depression dimensions in mood disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2017.02.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}